Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Tech

Contakt World launches its Research, Development, Training division to spearhead continued development of breakthrough public health and safety technologies

The division is expected to play a critical role in non-dilutive capital formation for Contakt World through recurring applications for grants bolstered by the expertise and scale of the FreeMind Group

Contakt World LLC, a technology company modernizing public health and safety, has launched its Research, Development, Training (RDT) division to spearhead continued development of breakthrough public health and safety technologies by conducting university research and by seeking funding through non-dilutive grants.

The RDT division is expected to play a critical role in non-dilutive capital formation for Contakt World through recurring applications for grants bolstered by the expertise and scale of the FreeMind Group, which has successfully garnered over US$1.5 billion in awards for its clients.

FreeMind will assist Contakt World with strategy and frequent applications from agencies in the United States such as National Institutes of Health (NIH), Department of Defense (DoD), Biomedical Advanced Research Development Authority (BARDA), National Science Foundation (NSF) and through private foundations.

READ: Contakt World named a winner for best product in the 2021 BIG Innovation Awards presented by the Business Intelligence Group

Through academic research partnerships, internal consultations, its engagement of FreeMind and internal and external training programs, the RDT division will support Contact World’s goal to connect health agencies with their communities. Leveraging FreeMind’s expertise, the RDT division is expected to fund commercial deployment of Contakt World solutions to under-resourced local health agencies, identify gaps that exist in public health agency technologies, improve existing solutions and develop new solutions that improve public health and safety for a mid and post-pandemic world.

“The RDT division demonstrates Contakt World’s commitment to health equity, serving vulnerable populations and innovation in public health, which has been historically under-resourced and underappreciated,” said Dr Riaz Ferdaus, VP of Research at Contakt World in a statement.

“We hope that our programs, which are specifically guided or driven by meaningful academic research and affiliations with leading associations like the National Association of County and City Health Officials, will improve contact tracing, trust in vaccines and health agency resources. With our recent retention of FreeMind, we hope to financially support our programs with non-dilutive capital through grants and further establish Contakt World as an industry leader in public health and safety," he added.

Key priorities for the RDT division include:

  • Establishing multiple academic research partnerships to create a pipeline of meaningful research to study vulnerable populations and disruptive innovation for public health. Initial research involving Contakt World commenced at the Sue and Bill Gross School of Nursing and University of California, Irvine in 2020, recently expanding to Franciscan Missionaries of Our Lady University (FranU) in Louisiana, and Augusta University in Georgia;
  • Developing grant programs that fund Contakt World to deploy its solutions in under-resourced health agencies, including but not limited to the approximately 2,000 local health agencies in the United States which presently serve populations of less than 50,000; and
  • Creating internal and external training and education modules to support deployment and enhance scalability of Contakt World’s public health and safety technologies, including its contact tracing platform and community messaging solutions.

Contakt World has the goal of becoming the most trustworthy, accessible and scalable digital public health and safety platform globally, and addressing the needs of a post-pandemic world. The group combines aggressive research and development, human-centered design, next-gen data integrations, and strategic health partnerships to empower and build mutual trust within communities, contributing towards health equity for users around the world.

The company’s first suite of tools emerged from the urgency surrounding coronavirus to manage the pandemic through innovative contact tracing and case management spanning multiple modes of communication.

Tracker Ventures Corp. (CSE:TKR) (OTCMKTS:TLOOF) FRA:B2I), an analytics software company that leverages blockchain and digital asset technology to transform and modernize multiple industries, is currently pursuing the acquisition of Contakt World. Tracker is taking a diversified approach to the analytics and technology space, delivering practical solutions in the health, finance, logistics and pharmaceutical industries. The company’s turnkey real-time tracking solutions offer the very latest in IoT and AI, providing valuable data and business intelligence to some of the world’s leading brands.

Contact the author at jon.hopkins@proactiveinvestors.com

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK